| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |